BSECompany Update9 Oct 2026 · 9 Oct 2026, 05:47 pm

Please find enclosed Press Release titled 'CPHI Milan 2026: Opening doors to regulated markets and new global business opportunities' issued on October 09, 2026.

Trident Lifeline Ltd · 543616

✦ AI Summary▲ PositiveExpansion

Trident Lifeline Ltd has participated in CPHI Milan 2026, a trade fair in Italy, to expand its presence in regulated pharmaceutical markets. The company showcased its healthcare product portfolio and engaged with global pharmaceutical stakeholders to explore opportunities in these geographies.

Analysis Scores

Earnings Impact2/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact6/10
Market Sentiment7/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Trident Lifeline Ltd - 543616 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Attachments (1)

📄

afa4b570-0608-43a7-8873-f773e5bddc4c.pdf

pdf

Download →
View document text
October 09, 2026 BSE Limited Stock ID: TLL 14th Floor, P. J. Towers, Scrip Code: 543616 Dalal Street, Fort, ISIN: INE0MKA01014 Mumbai – 400001. Dear Sir/Madam, Sub: INTIMATION UNDER REGULATION 30 OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (“SEBI LISTING REGULATIONS”) ‐ PRESS RELEASE Please find enclosed Press Release titled “CPHI Milan 2026: Opening doors to regulated markets and new global business opportunities” issued on October 09, 2026. The copy of the same is attached herewith and will also be available on the Company’s website at: www.tridentlifeline.com Kindly take the above information on record. Thanking you. YOURS FAITHFULLY, FOR TRIDENT LIFELINE LIMITED RUPABEN CHETAN JARIWALA WHOLE TIME DIRECTOR DIN: 08543127 Registered Office: 2004, 2nd Floor, North Extension, Falsawadi, Ring Road, Surat-395003, Gujarat, INDIA. Tel : +91 261 2451274, 2451284 Email : info@tridentlifeline.com Web : www.tridentlifeline.com Factory Address: Plot No. 4240, Road No. 42, Sachin GIDC, Surat, Gujarat - 394230, India. PRESS & MEDIA RELEASE CPHI Milan 2026: Opening doors to regulated markets and new globalbusinessopportunities Surat,Gujarat-October9,2026–TridentLifelineLimited’sparticipation atCPHIMilan 2026, held fromOctober 6 to 8 at FieraMilano, Italy, marked an importantstep in the company’s efforts to expand its presence across targeted regulated pharmaceutical markets. The platform enabled the company to showcase its healthcare product portfolio and engage withglobalpharmaceutical stakeholders toexploreopportunities inthesegeographies. Buildingvisibilityintargetmarkets: ▪ Inroads into regulated markets: Participation at CPHI Milan served as a direct gateway for Trident Lifeline to navigate and establish credibility within high-bar, target regulatory geographies, accelerating globalcompliance mappingandmarketentry ▪ Unmatched global visibility: By exhibiting at the world's top-most trade fair category, Trident Lifeline secured significant international exposure,putting its pharmaceutical and healthcare portfoliofrontandshowcasing itscapabilities toglobalindustry buyers ▪ Organic high-volume walk-ins and unanticipated leads: The sheer scale of CPHI generated an organic customer walk-in base, connecting the company with valuable, high-intent prospective leads and surprising niche buyers from regions outside initial projections ▪ Actionable market intelligence: On-ground interactions provided Trident Lifeline’s leadership with critical, ground-level insights into shifting global pharma trends and buyer requirements, empowering the company to proactively adapt its strategies and capitalize onemerging shifts 01|TridentLifelineLimited PRESS & MEDIA RELEASE AboutTridentLifelineLimited: TridentLifelineLimited(“TridentLifeline”orthe“Company”)isapharmaceuticalandhealthcare company with expertise in manufacturing finished dose pharmaceutical products, with a growing presence across global markets. The Company offers a diversified portfolio spanning pharmaceuticals, nutraceuticals, herbal products, injectables, personal care and medical devices, catering to a broad range of healthcare needs. Its operations are supported by a hybrid manufacturing model combining strategic manufacturing partnerships with integrated capabilities, enabling scalability, product quality and supply reliability. Trident Lifeline focuses on delivering quality-led healthcare solutions across domestic and international markets, supported by regulatory-compliant manufacturing capabilities, an expanding product portfolio andanestablished globaldistribution network. Contact us: Company Investorrelationsconsultant TridentLifelineLimited NeoAtlasCapitalAdvisoryLLP NikitaSharma ResearchTeam CompanySecretary +91 6354947366 | research@atlascapital.in compliance@tridentlifeline.com Rutul Shah +91 8200247366 | rutul.shah@atlascapital.in Meeting Request Link Safeharbour Certainstatementsinthisdocumentthatarenothistoricalfactsareforwardlookingstatements.Suchforwardlooking statements are subject to certain risks and uncertainties like government actions, local, political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. Trident Lifeline Limited will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-lookingstatementstoreflectsubsequenteventsorcircumstances. 02|TridentLifelineLimited